These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 608498

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Murine lymph node natural killer cells: regulatory mechanisms of activation or suppression.
    Hisano G, Hanna N.
    J Natl Cancer Inst; 1982 Sep; 69(3):665-71. PubMed ID: 6180211
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Organ distribution of Corynebacterium parvum labeled with iodine-125.
    Dimitrov NV, Greenberg CS, Denny T.
    J Natl Cancer Inst; 1977 Feb; 58(2):287-94. PubMed ID: 833877
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Distribution of 3H-thymidine-labelled C. parvum in mice.
    Sadler TE, Cramp WA, Castro JE.
    Dev Biol Stand; 1977 Feb; 38():137-43. PubMed ID: 608501
    [Abstract] [Full Text] [Related]

  • 10. Modifications in the handling in vitro of 125I-labelled keyhole limpet haemocyanin by peritoneal macrophages from mice pretreated with the adjuvant Corynebacterium parvum.
    Wiener E, Bandieri A.
    Immunology; 1975 Aug; 29(2):265-74. PubMed ID: 1158386
    [Abstract] [Full Text] [Related]

  • 11. [Studies of the effects of BCG and Corynebacterium parvum vaccines in experimental infection of mice with influenza virus. Foot pad test, splenic indicator and histologic changes in the thymus gland, spleen and lymph nodes].
    Ciebiada I, Błoch P, Kulig A, Denys A.
    Med Dosw Mikrobiol; 1989 Aug; 41(2):92-9. PubMed ID: 2586194
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Conditions favouring the selection of either specific or non specific C. parvum-mediated, systemic antitumour immunity in mice.
    Scott MT.
    Dev Biol Stand; 1989 Aug; 38():273-6. PubMed ID: 415921
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enhancement and depression of the antibody response in mice caused by Corynebacterium parvum.
    Warr GW, Sljivić VS.
    Clin Exp Immunol; 1974 Jul; 17(3):519-32. PubMed ID: 4157122
    [Abstract] [Full Text] [Related]

  • 17. Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice.
    Milas L, Basic I, Kogelnik HD, Withers HR.
    Cancer Res; 1975 Sep; 35(9):2365-74. PubMed ID: 807323
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the antitumour activities of glucans and C. parvum.
    Bomford R, Moreno C.
    Dev Biol Stand; 1975 Sep; 38():291-5. PubMed ID: 608513
    [Abstract] [Full Text] [Related]

  • 19. Role of T-cell subsets in the destruction of established metastases of 13762A rat mammary adenocarcinoma.
    Howell LE, Kreider JW, Bartlett GL.
    J Natl Cancer Inst; 1986 Jul; 77(1):187-93. PubMed ID: 3487670
    [Abstract] [Full Text] [Related]

  • 20. Experience with the quality control testing of C. parvum suspension for clinical trial.
    Knight PA, Lucken RN.
    Dev Biol Stand; 1986 Jul; 38():51-8. PubMed ID: 608544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.